La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Applied Therapeutics Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Shoshana Shendelman
Amministratore delegato
US$9.5m
Compenso totale
| Percentuale dello stipendio del CEO | 6.6% |
| Mandato del CEO | 8.6yrs |
| Proprietà del CEO | 4.0% |
| Durata media del management | less than a year |
| Durata media del Consiglio di amministrazione | 7.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We're Hopeful That Applied Therapeutics (NASDAQ:APLT) Will Use Its Cash Wisely
Aug 01
Applied Therapeutics: Navigating Challenges In ARI Development For Rare Diseases
May 28Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible
Feb 16Is Applied Therapeutics (NASDAQ:APLT) In A Good Position To Deliver On Growth Plans?
Feb 16Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
Nov 13We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
Aug 11We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
May 19Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
Jan 19Is Applied Therapeutics (NASDAQ:APLT) Using Debt In A Risky Way?
Nov 11Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation
Aug 13Applied Therapeutics trades higher on FDA Fast Track designation for rare metabolic disorder
Jun 17Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
May 15Independent Director Stacy Kanter Just Bought 100% More Shares In Applied Therapeutics, Inc. (NASDAQ:APLT)
Feb 26How Much Of Applied Therapeutics, Inc. (NASDAQ:APLT) Do Insiders Own?
Feb 18Applied Therapeutics to resume galactosemia study for AT-007
Feb 02Applied Therapeutics, Inc. (NASDAQ:APLT) Insiders Have Been Selling
Nov 24
Applied Therapeutics EPS misses by $0.21
Nov 12Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$161m |
| Mar 31 2024 | n/a | n/a | -US$194m |
| Dec 31 2023 | US$9m | US$630k | -US$120m |
| Sep 30 2023 | n/a | n/a | -US$97m |
| Jun 30 2023 | n/a | n/a | -US$73m |
| Mar 31 2023 | n/a | n/a | -US$70m |
| Dec 31 2022 | US$3m | US$588k | -US$83m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$105m |
| Mar 31 2022 | n/a | n/a | -US$105m |
| Dec 31 2021 | US$2m | US$588k | -US$106m |
| Sep 30 2021 | n/a | n/a | -US$102m |
| Jun 30 2021 | n/a | n/a | -US$104m |
| Mar 31 2021 | n/a | n/a | -US$106m |
| Dec 31 2020 | US$5m | US$578k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$88m |
| Jun 30 2020 | n/a | n/a | -US$69m |
| Mar 31 2020 | n/a | n/a | -US$49m |
| Dec 31 2019 | US$12m | US$550k | -US$46m |
| Sep 30 2019 | n/a | n/a | -US$35m |
| Jun 30 2019 | n/a | n/a | -US$28m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$1m | US$500k | -US$17m |
Compensazione vs Mercato: La retribuzione totale di Shoshana ($USD 9.49M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 3.30M ).
Compensazione vs guadagni: La retribuzione di Shoshana è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Shoshana Shendelman (45 yo)
8.6yrs
Mandato
US$9,493,213
Compensazione
Dr. Shoshana Shendelman, PhD, has been Director of Applied Therapeutics Inc. since January 2016. Prior to founding Applied, she founded Clearpoint Strategy Group, a boutique life science consulting firm, w...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chair of the Board of Directors | no data | US$9.49m | 3.96% $ 26.8m | |
| CFO, Principal Financial Officer & Independent Director | less than a year | US$675.15k | 0.058% $ 391.3k | |
| Chief Medical Officer | 6yrs | US$3.04m | 0.13% $ 887.6k | |
| COO & Chief Business Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Accounting Officer | 1.2yrs | Nessun dato | Nessun dato | |
| Chief Commercial Officer | less than a year | Nessun dato | Nessun dato |
0.8yrs
Durata media
57.5yo
Età media
Gestione esperta: Il team dirigenziale di APLT non è considerato esperto (durata media 0.8 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chair of the Board of Directors | 8.6yrs | US$9.49m | 3.96% $ 26.8m | |
| CFO, Principal Financial Officer & Independent Director | 8.2yrs | US$675.15k | 0.058% $ 391.3k | |
| Independent Director | 7.6yrs | US$85.65k | 0.39% $ 2.7m | |
| Independent Director | 5.3yrs | US$92.53k | 0.017% $ 117.8k | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Lead Independent Director | 7.4yrs | US$88.78k | 0.053% $ 355.9k | |
| Independent Director | 5.3yrs | US$94.40k | 0.055% $ 371.1k | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Chairman of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato |
7.5yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di APLT sono considerati esperti (durata media dell'incarico 7.5 anni).